Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
Klaus G ParhoferMedical Department II Grosshadern, University of Munich, GermanyAbstract: Although statins reduce cardiovascular morbidity and mortality further risk reduction is needed. In this respect low HDL-cholesterol concentrations and/or elevated triglyceride concentrations may b...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-11-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/review-of-extended-release-niacinlaropiprant-fixed-combination-in-the--a3684 |